- United States
- /
- Chemicals
- /
- NasdaqGS:BIOX
Individual investors among Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) largest stockholders and were hit after last week's 22% price drop
Key Insights
- The considerable ownership by individual investors in Bioceres Crop Solutions indicates that they collectively have a greater say in management and business strategy
- 55% of the business is held by the top 5 shareholders
- Institutions own 16% of Bioceres Crop Solutions
Every investor in Bioceres Crop Solutions Corp. (NASDAQ:BIOX) should be aware of the most powerful shareholder groups. With 35% stake, individual investors possess the maximum shares in the company. Put another way, the group faces the maximum upside potential (or downside risk).
As a result, individual investors as a group endured the highest losses last week after market cap fell by US$41m.
Let's take a closer look to see what the different types of shareholders can tell us about Bioceres Crop Solutions.
View our latest analysis for Bioceres Crop Solutions
What Does The Institutional Ownership Tell Us About Bioceres Crop Solutions?
Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.
As you can see, institutional investors have a fair amount of stake in Bioceres Crop Solutions. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Bioceres Crop Solutions, (below). Of course, keep in mind that there are other factors to consider, too.
It would appear that 13% of Bioceres Crop Solutions shares are controlled by hedge funds. That's interesting, because hedge funds can be quite active and activist. Many look for medium term catalysts that will drive the share price higher. Bioceres S.A. is currently the largest shareholder, with 25% of shares outstanding. DRACO CAPITAL is the second largest shareholder owning 9.8% of common stock, and Fourth Sail Capital LP holds about 7.4% of the company stock. In addition, we found that Federico Trucco, the CEO has 0.5% of the shares allocated to their name.
To make our study more interesting, we found that the top 5 shareholders control more than half of the company which implies that this group has considerable sway over the company's decision-making.
Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. There are a reasonable number of analysts covering the stock, so it might be useful to find out their aggregate view on the future.
Insider Ownership Of Bioceres Crop Solutions
The definition of an insider can differ slightly between different countries, but members of the board of directors always count. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.
Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group.
Our most recent data indicates that insiders own some shares in Bioceres Crop Solutions Corp.. It has a market capitalization of just US$140m, and insiders have US$2.8m worth of shares, in their own names. This shows at least some alignment, but we usually like to see larger insider holdings. You can click here to see if those insiders have been buying or selling.
General Public Ownership
The general public-- including retail investors -- own 35% stake in the company, and hence can't easily be ignored. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.
Private Company Ownership
We can see that Private Companies own 34%, of the shares on issue. It's hard to draw any conclusions from this fact alone, so its worth looking into who owns those private companies. Sometimes insiders or other related parties have an interest in shares in a public company through a separate private company.
Next Steps:
While it is well worth considering the different groups that own a company, there are other factors that are even more important.
I like to dive deeper into how a company has performed in the past. You can find historic revenue and earnings in this detailed graph.
Ultimately the future is most important. You can access this free report on analyst forecasts for the company.
NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.
Valuation is complex, but we're here to simplify it.
Discover if Bioceres Crop Solutions might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NasdaqGS:BIOX
Excellent balance sheet and good value.
Similar Companies
Market Insights
Community Narratives



